Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Bocchi, Leonardo ^a   Savi, Monia ^a   Graiani, Gallia ^a   Rossi, Stefano ^a   Agnetti, Aldo ^a   Stillitano, Francesca ^b   Lagrasta, Costanza ^a   Baruffi, Silvana ^a   Berni, Roberta ^a   Frati, Caterina ^a   Vassalle, Mario ^c   Squarcia, Umberto ^a   Cerbai, Elisabetta ^b   Macchi, Emilio ^a   Stilli, Donatella ^a   Quaini, Federico ^a   Musso, Ezio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODEOXYCYTIDINE; BROXURIDINE; CONNEXIN 43; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; POTASSIUM CHANNEL; POTASSIUM CHANNEL ALPHA SUBUNIT KV1.4; POTASSIUM CHANNEL ALPHA SUBUNIT KV4.2; POTASSIUM CHANNEL ALPHA SUBUNIT KV4.3; PROTEIN KCHIP2 BETA SUBUNIT; SCATTER FACTOR; SOMATOMEDIN C; UNCLASSIFIED DRUG; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; BETA CHAIN; CARDIAC STEM CELL; CELL REGENERATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE EXCITABILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; MALE; NERVE CONDUCTION; NONHUMAN; PROTEIN EXPRESSION; QT INTERVAL; RAT; STEM CELL; STEM CELL MOBILIZATION; TELEMETRY; TISSUE REGENERATION; WISTAR RAT; ANIMAL; CYTOLOGY; DISEASE MODEL; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ARRHYTHMIAS, CARDIAC; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 79952800292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017750     Document Type: Article

References (56)

1. Marbán E, Cheng K, (2010) Heart to heart: The elusive mechanism of cell therapy. Circulation 121: 1981-1984.
2. Dimmeler S, Zeiher AM, Schneider MD, (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115: 572-583.
3. Joggerst SJ, Hatzopoulos AK, (2009) Stem cell therapy for cardiac repair: benefits and barriers. Expert Rev Mol Med 11: e20.
4. Leri A, Kajstura J, Anversa P, (2005) Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85: 1373-1416.
5. Chen HS, Kim C, Mercola M, (2009) Electrophysiological challenges of cell-based myocardial repair. Circulation 120: 2496-2508.
6. Ly HQ, Nattel S, (2009) Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation 119: 1824-1831.
7. Macia E, Boyden PA, (2009) Stem cell therapy is proarrhythmic. Circulation 119: 1814-1823.
8. Menasché P, (2009) Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation 119: 2735-2740.
9. Smith RR, Barile L, Messina E, Marbán E, (2008) Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. Heart Rhythm 5: 880-887.
10. Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, et al. (2008) Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51: 933-943.
11. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, et al. (2006) G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 203: 87-97.
12. Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, et al. (2007) Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 42: 304-314.
13. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, et al. (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450: 819-824.
14. Gepstein L, Ding C, Rehemedula D, Wilson EE, Yankelson L, et al. (2010) In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 28: 2151-2161.
15. Wang D, Zhang F, Shen W, Chen M, Yang B, et al. (2010) Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol Epub of print (DOI: 10.1016/j.ijcard.2010.07.025).
16. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
17. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, et al. (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100: 12313-12318.
18. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, et al. (2004) Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265: 262-275.
19. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, et al. (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95: 911-921.
20. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, et al. (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653.
21. Limana F, Zacheo A, Mocini D, Mangoni A, Borsellino G, et al. (2007) Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res 101: 1255-1265.
22. Davis DR, Kizana E, Terrovitis J, Barth AS, Zhang Y, et al. (2010) Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart. J Mol Cell Cardiol 49: 312-321.
23. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, et al. (2002) Chimerism of the transplanted heart. N Engl J Med 346: 5-15.
24. Chamuleau SA, Vrijsen KR, Rokosh DG, Tang XL, Piek JJ, et al. (2009) Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J 17: 199-207.
25. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, et al. (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 102: 3766-3771.
26. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, et al. (2005) Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673.
27. Linke A, Müller P, Nurzynska D, Casarsa C, Torella D, et al. (2005) Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 102: 8966-8971.
28. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, et al. (2008) Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103: 107-116.
29. Gheorghiade M, Bonow RO, (1998) Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97: 282-289.
30. Kjekshus J, (1990) Arrhythmias and mortality in congestive heart failure. Am J Cardiol 65: 421-481.
31. Sgoifo A, Stilli D, Medici D, Gallo P, Aimi B, et al. (1996) Electrode positioning for reliable telemetry ECG recordings during social stress in unrestrained rats. Physiol Behav 60: 1397-1401.
32. Martinez M, Calvo Torrent A, Pico Alfonso MA, (1998) Social defeat and subordination as models of social stress in laboratory rodents: a review. Aggress Behav 24: 241-256.
33. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 93: 1043-1075.
34. Pollick C, Hale SL, Kloner RA, (1995) Echocardiographic and cardiac Doppler assessment of mice. J Am Soc Echocardiogr 8: 602-610.
35. Macchi E, Cavalieri M, Stilli D, Musso E, Baruffi S, et al. (1998) High-density epicardial mapping during current injection and ventricular activation in rat hearts. Am J Physiol Heart Circ Physiol 275: H1886-1897.
36. Ogawa S, Furuno I, Satoh Y, Yoh S, Saeki K, et al. (1991) Quantitative indices of dispersion of refractoriness for identification of propensity to re-entrant ventricular tachycardia in a canine model of myocardial infarction. Cardiovasc Res 25: 378-383.
37. Mitchell GF, Jeron A, Koren G, (1998) Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol Heart Circ Physiol 274: H747-H751.
38. Fuller MS, Sándor G, Punske B, Taccardi B, MacLeod RS, et al. (2000) Estimates of repolarization dispersion from electrocardiographic measurements. Circulation 102: 685-691.
39. Dodge HT, Baxley WA, (1969) Left ventricular volume and mass and their significance in heart disease. Am J Cardiol 23: 528-537.
40. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P, (1991) Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 68: 856-869.
41. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344-10349.
42. Stilli D, Lagrasta C, Berni R, Bocchi L, Savi M, et al. (2007) Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. Basic Res Cardiol 102: 488-499.
43. van Rijen HV, van Veen TA, Gros D, Wilders R, de Bakker JM, (2006) Connexins and cardiac arrhythmias. Adv Cardiol 42: 150-160.
44. Kolettis TM, (2006) Arrhythmogenesis after cell transplantation post-myocardial infarction. Four burning questions-and some answers. Cardiovasc Res 69: 299-301.
45. Stilli D, Berni R, Bocchi L, Zaniboni M, Cacciani F, et al. (2004) Vulnerability to ventricular arrhythmias and heterogeneity of action potential duration in normal rats. Exp Physiol 89: 387-396.
46. Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, et al. (2007) Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115: 2254-2261.
47. Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, et al. (2003) Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a swine model of myocardial infarction. J Cardiac Electrophysiol 14: 841-848.
48. van der Heyden MA, Wijnhoven TJ, Opthof T, (2006) Molecular aspects of adrenergic modulation of the transient outward current. Cardiovasc Res 71: 430-442.
49. Marionneau C, Brunet S, Flagg TP, Pilgram TK, Demolombe S, et al. (2008) Distinct cellular and molecular mechanisms underlie functional remodeling of repolarizing K+ currents with left ventricular hypertrophy. Circ Res 102: 1406-1415.
50. Tozakidou M, Goltz D, Hagenström T, Budack MK, Vitzthum H, et al. (2010) Molecular and functional remodeling of I(to) by angiotensin II in the mouse left ventricle. J Mol Cell Cardiol 48: 140-151.
51. Duffy HS, (2008) Cardiac Connections-The Antiarrhythmic Solution? N Engl J Med 358: 1397-1398.
52. Fozzard HA, (2001) Gap junctions and liminal length in hypertrophy: something old and something new. J Cardiovasc Electrophysiol 12: 836-837.
53. Fozzard HA, Schoenberg M, (1972) Strength-duration curves in cardiac Purkinje fibres: effects of liminal length and charge distribution. J Physiol 226: 593-618.
54. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699.
55. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221.
56. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, et al. (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783.